These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1234 related articles for article (PubMed ID: 27059391)
1. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Gitler AD; Tsuiji H Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene. Wen X; Westergard T; Pasinelli P; Trotti D Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540 [TBL] [Abstract][Full Text] [Related]
3. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions. Todd TW; Petrucelli L J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Neurodegeneration Related to Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737 [TBL] [Abstract][Full Text] [Related]
5. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD. Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007 [TBL] [Abstract][Full Text] [Related]
7. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382 [TBL] [Abstract][Full Text] [Related]
9. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Farg MA; Konopka A; Soo KY; Ito D; Atkin JD Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984 [TBL] [Abstract][Full Text] [Related]
11. RNA-mediated toxicity in C9orf72 ALS and FTD. McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028 [TBL] [Abstract][Full Text] [Related]
12. SFPQ regulates the accumulation of RNA foci and dipeptide repeat proteins from the expanded repeat mutation in Malnar M; Rogelj B J Cell Sci; 2021 Feb; 134(4):. PubMed ID: 33495278 [TBL] [Abstract][Full Text] [Related]
13. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Beckers J; Tharkeshwar AK; Van Damme P Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058 [TBL] [Abstract][Full Text] [Related]
14. Disease Mechanisms of Gendron TF; Petrucelli L Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314 [TBL] [Abstract][Full Text] [Related]
15. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)]. Tomiyama H Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305 [TBL] [Abstract][Full Text] [Related]
16. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders. Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438 [TBL] [Abstract][Full Text] [Related]
17. C9orf72; abnormal RNA expression is the key. Heutink P; Jansen IE; Lynes EM Exp Neurol; 2014 Dec; 262 Pt B():102-10. PubMed ID: 24873727 [TBL] [Abstract][Full Text] [Related]
18. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Almeida S; Gascon E; Tran H; Chou HJ; Gendron TF; Degroot S; Tapper AR; Sellier C; Charlet-Berguerand N; Karydas A; Seeley WW; Boxer AL; Petrucelli L; Miller BL; Gao FB Acta Neuropathol; 2013 Sep; 126(3):385-99. PubMed ID: 23836290 [TBL] [Abstract][Full Text] [Related]
19. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860 [TBL] [Abstract][Full Text] [Related]
20. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia. Verma A Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]